These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33429029)

  • 41. COVID-19 in African Countries versus other World Regions: A Review.
    Kaba AJ; Kaba AN
    Afr J Reprod Health; 2020 Jun; 24(s1):125-141. PubMed ID: 34077062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increase in COVID-19 cases and case-fatality and case-recovery rates in Europe: A cross-temporal meta-analysis.
    Karadag E
    J Med Virol; 2020 Sep; 92(9):1511-1517. PubMed ID: 32437052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Healthcare workers' knowledge, preparedness, counselling practices, and perceived barriers to confront COVID-19: A cross-sectional study from a war-torn country, Yemen.
    Al-Ashwal FY; Kubas M; Zawiah M; Bitar AN; Mukred Saeed R; Sulaiman SAS; Khan AH; Ghadzi SMS
    PLoS One; 2020; 15(12):e0243962. PubMed ID: 33306750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID-19 in Mexico.
    Parra-Bracamonte GM; Parra-Bracamonte FE; Lopez-Villalobos N; Lara-Rivera AL
    Nephrology (Carlton); 2021 Mar; 26(3):248-251. PubMed ID: 33184959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New COVID-19 resurgence in the WHO Eastern Mediterranean region.
    Nabeth P; Hassan M; Adib K; Abubakar A; Brennan R
    Lancet; 2021 Apr; 397(10282):1348-1349. PubMed ID: 33773609
    [No Abstract]   [Full Text] [Related]  

  • 46. COVID-19 in children: analysis of the first pandemic peak in England.
    Ladhani SN; Amin-Chowdhury Z; Davies HG; Aiano F; Hayden I; Lacy J; Sinnathamby M; de Lusignan S; Demirjian A; Whittaker H; Andrews N; Zambon M; Hopkins S; Ramsay ME
    Arch Dis Child; 2020 Dec; 105(12):1180-1185. PubMed ID: 32796006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Covid-19, equity, and inclusiveness.
    Evans NG; Berger ZD; Phelan AL; Silverman RD
    BMJ; 2021 Jun; 373():n1631. PubMed ID: 34187843
    [No Abstract]   [Full Text] [Related]  

  • 48. Understanding the Differences in COVID-19 Case Fatality Rates Observed Across Alabama Counties.
    Velayati A; Dahale D; Dahlin A; Hamilton C; Provost LP; Erwin P
    J Public Health Manag Pract; 2021 May-Jun 01; 27(3):305-309. PubMed ID: 33762546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Countries with delayed COVID-19 introduction - characteristics, drivers, gaps, and opportunities.
    Li Z; Jones C; Ejigu GS; George N; Geller AL; Chang GC; Adamski A; Igboh LS; Merrill RD; Ricks P; Mirza SA; Lynch M
    Global Health; 2021 Mar; 17(1):28. PubMed ID: 33731178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19 in Yemen: preparedness measures in a fragile state.
    Dureab F; Al-Awlaqi S; Jahn A
    Lancet Public Health; 2020 Jun; 5(6):e311. PubMed ID: 32334648
    [No Abstract]   [Full Text] [Related]  

  • 51. Perspective of Covid-19 pandemic in South Asian countries.
    Murtaza G; Imdad K; Arshad M; Hamza A; Aslam A; Bashir S
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13098-13100. PubMed ID: 33378063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three million COVID deaths is a grim milestone.
    Nature; 2021 Apr; 592(7855):488. PubMed ID: 33883738
    [No Abstract]   [Full Text] [Related]  

  • 53. Rapid coronavirus tests: a guide for the perplexed.
    Guglielmi G
    Nature; 2021 Feb; 590(7845):202-205. PubMed ID: 33564189
    [No Abstract]   [Full Text] [Related]  

  • 54. COVID-19: Defining an invisible enemy within healthcare and the community.
    Musa SA; Sivaramakrishnan A; Paget S; El-Mugamar H
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):495-497. PubMed ID: 32507120
    [No Abstract]   [Full Text] [Related]  

  • 55. Disparities in SARS-CoV-2 Testing in Massachusetts During the COVID-19 Pandemic.
    Dryden-Peterson S; Velásquez GE; Stopka TJ; Davey S; Lockman S; Ojikutu BO
    JAMA Netw Open; 2021 Feb; 4(2):e2037067. PubMed ID: 33560423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 infection rates in patients referred for psychiatric admission during a regional surge: The case for universal testing.
    Brody BD; Shi Z; Shaffer C; Eden D; Wyka K; Alexopoulos GS; Parish SJ; Kanellopoulos D
    Psychiatry Res; 2021 Apr; 298():113833. PubMed ID: 33657449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What two US counties will tell us about COVID-19.
    Nat Biotechnol; 2021 May; 39(5):533. PubMed ID: 33981080
    [No Abstract]   [Full Text] [Related]  

  • 58. Successful implementation of SARS-CoV-2 testing in midst of pandemic with emphasis on all phases of testing.
    Petersen JM; Dalal S; Jhala D
    J Clin Pathol; 2021 May; 74(5):273-278. PubMed ID: 33731334
    [No Abstract]   [Full Text] [Related]  

  • 59. Political stigma of communicable diseases in complex emergencies.
    Bellizzi S; Bassat Q; Pichierri G; Cegolon L; Panu Napodano CM; Farina G; Murgia P; Ali Maher O
    J Infect Dev Ctries; 2021 May; 15(5):747-748. PubMed ID: 34106901
    [No Abstract]   [Full Text] [Related]  

  • 60. COVID-19 Laboratory Testing/CDC Guidelines.
    McFee DRB
    Dis Mon; 2020 Sep; 66(9):101067. PubMed ID: 32883517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.